🔑 Key Takeaways
- Brand-name GLP-1 drugs (Ozempic, Wegovy, Mounjaro, Zepbound) cost $900–$1,400/month without insurance
- Compounded semaglutide and tirzepatide are available via telehealth for $100–300/month
- Research peptide forms (semaglutide, tirzepatide, retatrutide) cost $40–200/vial from US vendors
- Manufacturer coupons can reduce cost to $25/month — but income limits are strict
- Retatrutide has no brand-name equivalent yet — only available as a research peptide
GLP-1 medications have transformed weight loss — but without insurance, the brand-name versions cost between $900 and $1,400 every month. Most people can't sustain that. The good news: there are legitimate alternatives that cost a fraction of the price. This guide covers every real option, from manufacturer programs to compounded pharmacy telehealth to research peptide vendors.
Why GLP-1s Are So Expensive Without Insurance
Here's what you're actually looking at for brand-name GLP-1 medications without insurance coverage:
| Drug | Monthly Cost (No Insurance) |
|---|---|
| Ozempic (semaglutide, diabetes) | ~$936 |
| Wegovy (semaglutide, weight loss) | ~$1,349 |
| Mounjaro (tirzepatide, diabetes) | ~$1,023 |
| Zepbound (tirzepatide, weight loss) | ~$550 with savings card |
Most insurance plans will cover these drugs for type 2 diabetes — that's where the original approval was. Weight loss is a different story. Most major insurers still classify GLP-1 weight loss treatment as elective, which means no coverage and full retail price.
Novo Nordisk and Eli Lilly both run discount programs, but eligibility is strictly income-based and excludes Medicare and Medicaid recipients. Most working adults earning a middle-class income don't qualify. So what are the real options?
Option 1 — Manufacturer Savings Programs
Both Novo Nordisk and Eli Lilly have patient assistance programs. They're not advertised loudly, but they exist.
Novo Nordisk Patient Assistance (NovoCare): Covers Ozempic and Wegovy. For qualifying patients, medication can be free or heavily reduced. Income limit is typically under 400% of the federal poverty level — roughly under $58,000/year for a single person in 2025.
Eli Lilly Insulin Value Program / Mounjaro Savings Card: The savings card can bring Mounjaro down to $25/month for eligible commercially-insured patients. "Commercially insured" is the key phrase — people on Medicare or Medicaid don't qualify. Uninsured patients may qualify for the patient assistance program at $0 through LillyAnswers.
Who qualifies: Households under 400% federal poverty level, not enrolled in government insurance (Medicare/Medicaid), with a valid prescription.
Option 2 — Compounded GLP-1 Via Telehealth
During the semaglutide and tirzepatide shortage that started in 2022, the FDA allowed compounding pharmacies to produce these medications legally. That opening created an entire telehealth industry around compounded GLP-1s — and it's still operating, though regulations are shifting in 2026.
Platforms like Hims, Ro, Henry Meds, and others offer telehealth consultations and connect patients with compounding pharmacies. The cost: typically $100–300/month depending on the platform and compound. That's a massive reduction from brand-name pricing.
What you get: A real prescription, a licensed pharmacy, and usually some level of medical supervision. Compounded semaglutide and tirzepatide contain the same active ingredient as Ozempic and Mounjaro — the difference is in the manufacturing process and quality control.
On 2026 regulations: The FDA shortage designation that enabled widespread compounding is being phased out. Some platforms are adapting to new rules; others may not survive the shift. Confirm the platform's compliance status before committing to a subscription.
Best for: people who want a prescription-backed version with medical oversight, and are comfortable paying $150–300/month.
Option 3 — Research Peptide Vendors (No Prescription)
Semaglutide, tirzepatide, and retatrutide are all available as research peptides from US-based vendors without a prescription. This is the lowest-cost option by a meaningful margin — and also the most hands-on.
Ascension Peptides carries the full GLP-1 peptide lineup:
- S-5 (Semaglutide 5mg) — $44
- T-10 (Tirzepatide 10mg) — $80
- T-30 (Tirzepatide 30mg) — $125
- R-10 (Retatrutide 10mg) — $120
- R-30 (Retatrutide 30mg) — $200
The trade-off: these come as lyophilized powder requiring reconstitution with bacteriostatic water before injection. No pre-filled pen. You mix it yourself, draw the dose, and inject subcutaneously. More involved than a Novo FlexPen — but manageable if you've worked with injectables before.
No medical supervision comes with this route. It's entirely self-managed. Before ordering, read our full guide on buying peptides online for what to look for in a vendor.
| Option | Cost/Month | Prescription? | Brand Name? |
|---|---|---|---|
| Brand-name Ozempic | $936 | Yes | Yes |
| Brand-name Wegovy | $1,349 | Yes | Yes |
| Brand-name Mounjaro | $1,023 | Yes | Yes |
| Compounded semaglutide (telehealth) | $100–300 | Yes | No |
| Research semaglutide (Ascension S-5) | ~$44–88 | No | No |
| Research tirzepatide (Ascension T-30) | ~$125 | No | No |
| Research retatrutide (Ascension R-30) | ~$200 | No | No |
Retatrutide — The Option With No Brand-Name Version
Here's something that gets overlooked in most GLP-1 cost comparisons: retatrutide doesn't have a brand-name version yet. It's still in Phase 3 clinical trials. If you want access to it right now, research peptide vendors are literally the only option — there's no prescription pathway because there's no approved drug.
Why does that matter? Retatrutide is a triple agonist — it activates GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 trial data showed approximately 24% body weight reduction in 48 weeks, compared to roughly 15% for semaglutide. That's a real difference.
R-30 (30mg vial from Ascension, $200) lasts approximately 10–15 weeks at standard dosing. That works out to $13–20/week. For the most potent GLP-1-class compound currently accessible, that's a number most people weren't expecting.
For full dosing protocols, see the retatrutide dosage chart.
GLP-1 Dosage Costs Comparison (Research Peptide)
Let's do the actual math at standard dosing:
| Compound | Vial / Price | Standard Weekly Dose | Weeks per Vial | Cost/Week |
|---|---|---|---|---|
| Semaglutide S-5 | 5mg / $44 | 1mg/week | ~5 weeks | ~$8.80 |
| Tirzepatide T-30 | 30mg / $125 | 5mg/week | ~6 weeks | ~$20.83 |
| Retatrutide R-30 | 30mg / $200 | 2mg/week | ~15 weeks | ~$13.33 |
Retatrutide ends up as one of the more cost-efficient options per week despite having the highest sticker price per vial — the dosing is lower relative to the total amount, so each vial stretches much further.
💡 Pro Tip
BAC water is sold separately. A 10mL vial (~$8–12) is enough to reconstitute multiple peptide vials. Grab a pack of 31g 5/16" insulin syringes for subcutaneous injection. Total setup cost for your first order: roughly $20–30 extra.
What to Watch Out For
- ❌ Unlicensed telehealth platforms offering GLP-1s without any medical assessment — a legitimate platform will always include a medical evaluation before prescribing
- ❌ Peptide vendors with no COA or purity testing — always request a Certificate of Analysis from an independent lab before ordering
- ❌ "Oral GLP-1" supplements — these products use the term GLP-1 as marketing language. They are not GLP-1 receptor agonists and work completely differently, if at all
- ❌ Vendors shipping from overseas with no US presence — quality and customs risk both increase significantly with overseas sourcing
- ❌ Prices dramatically below market rate — semaglutide at $15/vial, tirzepatide at $25/vial almost certainly indicates underdosed or counterfeit product
Frequently Asked Questions
The information in this article is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting any new supplement or compound. Results vary by individual.